(This article has been updated to include a response from Rite Aid.)
A third large U.S. pharmacy chain announced plans to carry CBD products in two states starting this month, following the trend of major retailers cashing in on the demand for hemp-derived CBD.
Rite Aid will begin selling topicals – including creams, lotions and lip balms – in more than 200 stores across Oregon and Washington this month, CNBC reports.
“Rite Aid has heard from many customers about their interest in purchasing CBD products,” a company spokesman said in an e-mail to Hemp Industry Daily.
“As a result, Rite Aid will begin the sale of CBD hemp oil products this month in more than 200 stores in Oregon and Washington.”
“We will begin piloting the sale of CBD creams, lotions and lip balms to better meet the needs and preferences of our customers in those communities.”
Rite Aid did not name the brands it plans to carry.
Last month, CVS signed a deal with Massachusetts-based CuraLeaf, a vertically integrated cannabis company, to sell its products at 800 stores in eight states, underscoring the opportunity for CBD product manufacturers to land mainstream distribution deals.
Soon after, Walgreens said it will sell CBD-infused creams, sprays and transdermal patches in 1,500 stores across nine states.
Traditional retailers Sephora, Ulta Beauty, Neiman Marcus, Barneys and DSW also sell hemp-derived products.
Meanwhile, the U.S. Food and Drug Administration (FDA) continues to hold the position that it is illegal to include CBD in food, cosmetics and dietary supplements. The federal agency sent yet another round of warning letters to CBD manufacturers this month.
The FDA announced last week that it will hold a public hearing May 31 to gather “scientific data and information” about CBD and other cannabis extracts.
